Cover Image
市場調查報告書

全球體外診斷(IVD)市場分析

Analysis of the Global In Vitro Diagnostics Market

出版商 Frost & Sullivan 商品編碼 269959
出版日期 內容資訊 英文 154 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球體外診斷(IVD)市場分析 Analysis of the Global In Vitro Diagnostics Market
出版日期: 2014年07月22日 內容資訊: 英文 154 Pages
簡介

全球體外診斷(IVD)市場穩定發展。2013年的市場規模是473億美元,預計2017年達到626億美元,以CAGR7.3%成長。

本報告提供全球體外診斷(IVD)市場相關調查分析、市場概要、推動因素、阻礙因素、預測與趨勢、市場佔有率和競爭分析等相關,整體市場/各市場區隔之有系統的資訊。

本調查涵蓋內容

  • 成長的部門為何?其成長將持續到何時?成長率是多少?
  • 競爭企業維持成長的主要策略為何?
  • 主要的收購與合併交易為何?
  • 全球/新興市場上主要推動因素與阻礙因素為何?
  • 各地區市場的分配為何?急速成長的地區為何?
  • 下一代序列(NGS)之後的新技術為何?

第1章 摘要整理

第2章 市場概要

  • 市場概要 - 定義
  • 市場區隔

第3章 外部環境的相關課題:推動因素與阻礙因素 - 綜合IVD市場

  • 推動市場要素
  • 推動因素的內容
  • 阻礙市場要素
  • 阻礙因素的內容
  • 新興市場受到關注 - 推動市場要素
  • 新興市場受到關注 - 阻礙市場要素

第4章 預測與趨勢 - 綜合IVD市場

  • 評估
  • 綜合IVD市場 - 收益預測
  • 收益預測的考察

第5章 市場佔有率和競爭分析 - 綜合IVD市場

  • 競爭情形
  • 市場佔有率分析
  • 競爭環境
  • 競爭要素 - M&A

第6章 免疫化學檢查

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 競爭環境
  • 設置台數
  • 產品分析
  • 產品清單
  • 通用檢驗

第7章 血糖自我檢測(SMBG)

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 市場佔有率分析
  • 競爭環境
  • 產品清單

第8章 重點照護(POC)檢驗

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 市場佔有率分析
  • 競爭環境

第9章 分子診斷

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 市場佔有率分析
  • 競爭環境
  • 產品清單

第10章 血液檢驗

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 市場佔有率分析
  • 競爭環境
  • 設置台數
  • 產品清單

第11章 臨床微生物檢驗

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 市場佔有率分析
  • 競爭環境
  • 技術趨勢

第12章 止血檢驗

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 市場佔有率分析
  • 競爭環境
  • 檢驗
  • 產品清單

第13章 組織診斷

  • 概要
  • 市場工程評量
  • 收益預測
  • 收益預測的考察
  • 競爭分析 - 市場佔有率
  • 競爭結構

第14章 各地區

  • 收益率的預測:各地區
  • 地區的成長率
  • 美國的收益預測
  • 西歐的收益預測
  • 亞太地區的收益預測
  • 巴西的收益預測
  • 東歐的收益預測
  • 其他地區的收益預測

第15章 彙整

第16章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: NE3E-01-00-00-00

Slowing US and European Markets Demand Alignment with Global Market Needs

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, companies are heavily focused on globalization in emerging economies such as China and Brazil. This research service discusses the IVD segments of immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose.

Key Questions This Study Will Answer

  • Which segments of the market are growing, how long will they continue to grow, and at what rate?
  • What primary strategies are competitors employing to sustain growth?
  • What do the key M&A deals indicate about the market?
  • What are the drivers and restraints for the global IVD market and for emerging markets?
  • What percentage does each region contribute to the global IVD market? Which regions are growing the fastest?
  • Which new technologies following next-generation sequencing (NGS) have the potential to be IVD applications?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Executive Summary
  • 2. Executive Summary (continued)
  • 3. Executive Summary (continued)
  • 4. Scope and Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Methodology

2. MARKET OVERVIEW

Market Overview

  • 1. Market Overview-Definitions
  • 2. Market Segmentation

3. EXTERNAL CHALLENGES: DRIVERS AND RESTRAINTS-TOTAL IVD MARKET

External Challenges: Drivers and Restraints-Total IVD Market

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Drivers Explained (continued)
  • 6. Market Restraints
  • 7. Restraints Explained
  • 8. Restraints Explained (continued)
  • 9. Restraints Explained (continued)
  • 10. Restraints Explained (continued)
  • 11. Focus on Emerging Markets-Market Drivers
  • 12. Focus on Emerging Markets-Market Restraints

4. FORECASTS AND TRENDS-TOTAL IVD MARKET

Forecasts and Trends-Total IVD Market

  • 1. Measurements
  • 2. Measurements (continued)
  • 3. Total IVD Market-Revenue Forecast
  • 4. Revenue Forecast Discussion

5. MARKET SHARE AND COMPETITIVE ANALYSIS- TOTAL IVD MARKET

Market Share and Competitive Analysis- Total IVD Market

  • 1. Competitive Analysis-Market Share
  • 2. Market Share Analysis
  • 3. Competitive Environment
  • 4. Competitive Factors-Mergers & Acquisitions

6. IMMUNOCHEMISTRY SEGMENT BREAKDOWN

Immunochemistry Segment Breakdown

  • 1. Immunochemistry Segment-Overview
  • 2. Immunochemistry Segment-Market Engineering Measurements
  • 3. Immunochemistry Segment-Revenue Forecast
  • 4. Immunochemistry Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Competitive Analysis-Market Share (continued)
  • 7. Immunochemistry Segment-Competitive Environment
  • 8. Immunochemistry Segment-Installed Base
  • 9. Immunochemistry Segment-Product Analysis
  • 10. Immunochemistry Segment-Product Analysis (continued)
  • 11. Immunochemistry Segment-Product List
  • 12. Immunochemistry Segment-Product List (continued)
  • 13. Immunochemistry Segment-Product List (continued)
  • 14. Immunochemistry Segment-Common Tests
  • 15. Immunochemistry Segment-Common Tests (continued)

7. SELF-MONITORING BLOOD GLUCOSE SEGMENT BREAKDOWN

Self-monitoring Blood Glucose Segment Breakdown

  • 1. SMBG Segment-Overview
  • 2. SMBG Segment-Market Engineering Measurements
  • 3. SMBG Segment-Revenue Forecast
  • 4. SMBG Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. SMBG Segment-Competitive Environment
  • 8. SMBG Segment-Product List

8. POINT-OF-CARE TESTING SEGMENT BREAKDOWN

Point-of-care Testing Segment Breakdown

  • 1. POCT Segment-Overview
  • 2. POCT Segment-Market Engineering Measurements
  • 3. POCT Segment-Revenue Forecast
  • 4. POCT Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. POCT Segment-Competitive Environment

9. MOLECULAR DIAGNOSTICS SEGMENT BREAKDOWN

Molecular Diagnostics Segment Breakdown

  • 1. Molecular Diagnostics Segment-Overview
  • 2. Molecular Diagnostics Segment-Overview (continued)
  • 3. Molecular Diagnostics Segment-Market Engineering Measurements
  • 4. Molecular Diagnostics Segment-Revenue Forecast
  • 5. Molecular Diagnostics Segment-Revenue Forecast Discussion
  • 6. Competitive Analysis-Market Share
  • 7. Market Share Analysis
  • 8. Molecular Diagnostics Segment-Competitive Environment
  • 9. Molecular Diagnostics Segment-Tests
  • 10. Molecular Diagnostics Segment-Product List
  • 11. Molecular Diagnostics Segment-Product List (continued)
  • 12. Molecular Diagnostics Segment-Product List (continued)
  • 13. Molecular Diagnostics Segment-Product List (continued)

10. HEMATOLOGY SEGMENT BREAKDOWN

Hematology Segment Breakdown

  • 1. Hematology Segment-Overview
  • 2. Hematology Segment-Market Engineering Measurements
  • 3. Hematology Segment-Revenue Forecast
  • 4. Hematology Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. Hematology Segment-Competitive Environment
  • 8. Hematology Segment-Installed Base
  • 9. Hematology Segment-Installed Base (continued)
  • 10. Hematology Segment-Product List
  • 11. Hematology Segment-Product List (continued)

11. CLINICAL MICROBIOLOGY SEGMENT BREAKDOWN

Clinical Microbiology Segment Breakdown

  • 1. Clinical Microbiology Segment-Overview
  • 2. Clinical Microbiology Segment-Market Engineering Measurements
  • 3. Clinical Microbiology Segment-Revenue Forecast
  • 4. Clinical Microbiology Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. Clinical Microbiology Segment-Competitive Environment
  • 8. Clinical Microbiology Segment-Technology Trends

12. HEMOSTASIS SEGMENT BREAKDOWN

Hemostasis Segment Breakdown

  • 1. Hemostasis Segment-Overview
  • 2. Hemostasis Segment-Market Engineering Measurements
  • 3. Hemostasis Segment-Revenue Forecast
  • 4. Hemostasis Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. Hemostasis Segment-Competitive Environment
  • 8. Hemostasis Segment-Tests
  • 9. Hemostasis Segment-Product List
  • 10. Hemostasis Segment-Product List (continued)

13. TISSUE DIAGNOSTICS SEGMENT BREAKDOWN

Tissue Diagnostics Segment Breakdown

  • 1. Tissue Diagnostics Segment Overview
  • 2. Tissue Diagnostics Segment Overview (continued)
  • 3. Tissue Diagnostics Segment-Market Engineering Measurements
  • 4. Tissue Diagnostics Segment-Revenue Forecast
  • 5. Tissue Diagnostics Segment-Revenue Forecast by Subsegment
  • 6. Tissue Diagnostics Segment-Revenue Forecast Discussion
  • 7. Competitive Analysis-Market Share
  • 8. Competitive Analysis-Market Share (continued)
  • 9. Competitive Structure

14. REGIONAL BREAKDOWN

Regional Breakdown

  • 1. Total IVD Market-Percent Revenue Forecast by Region
  • 2. Total IVD Market-Regional Growth
  • 3. IVD Market-US Revenue Forecast
  • 4. IVD Market-Western Europe Revenue Forecast
  • 5. IVD Market-Asia-Pacific and China Revenue Forecast
  • 6. IVD Market-Brazil Revenue Forecast
  • 7. IVD Market-Eastern Europe Revenue Forecast
  • 8. IVD Market-Rest of World Revenue Forecast

15. THE LAST WORD

The Last Word

  • 1. The Last Word-Three Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. Legal Disclaimer

16. APPENDIX

Appendix

  • 1. List of Other Companies-Total Market Level
  • 2. List of Other Companies-Segment Level
  • 3. List of Other Companies-US Tissue Diagnostics Segment
  • 4. Associated Multimedia
  • 5. Associated Multimedia (continued)
  • 6. Methodology
  • 7. Learn More-Next Steps

List of Exhibits

  • Total IVD Market: Market Engineering Measurements, Global, 2013
  • Total IVD Market: Market Segmentation, Global, 2013
  • Total IVD Market: Key Market Drivers, Global, 2014-2017
  • Total IVD Market: Key Market Restraints, Global, 2014-2017
  • Total IVD Market: Drivers for Emerging Markets, Global, 2014-2017
  • Total IVD Market: Restraints for Emerging Markets, Global, 2014-2017
  • Total IVD Market: Market Engineering Measurements, Global, 2013
  • Total IVD Market: Revenue Forecast, Global, 2012-2017
  • Total IVD Market: Percent of Sales, Global, 2013
  • Total IVD Market: Company Market Share Analysis of Top 12 Participants, Global, 2013
  • Total IVD Market: Competitive Structure, Global, 2013
  • Total IVD Market: Analysis of Key Mergers and Acquisitions, Global, 2013
  • Immunochemistry Segment: Market Engineering Measurements, Global, 2013
  • Immunochemistry Segment: Revenue Forecast, Global, 2012-2017
  • Immunochemistry Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Immunochemistry Segment: Competitive Structure, Global, 2013
  • Immunochemistry Segment: Installed Base, Global, 2013
  • Immunochemistry Segment: Number of Immunochemistry Analyzer Models and Configurations, Global, 2013
  • Immunochemistry Segment: List of Immunochemistry Analyzers, Global, 2013
  • Immunochemistry Segment: Common Clinical Chemistry Tests, Global, 2013
  • Immunochemistry Segment: Common Immunoassay Tests, Global, 2013
  • SMBG Segment: Market Engineering Measurements, Global, 2013
  • SMBG Segment: Revenue Forecast, Global, 2012-2017
  • SMBG Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • SMBG Segment: Competitive Structure, Global, 2013
  • SMBG Segment: Product List, Global, 2013
  • POCT Segment: Market Engineering Measurements, Global, 2013
  • POCT Segment: Revenue Forecast, Global, 2012-2017
  • POCT Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • POCT Segment: Competitive Structure, Global, 2013
  • Molecular Diagnostics Segment: Market Engineering Measurements, Global, 2013
  • Molecular Diagnostics Segment: Revenue Forecast, Global, 2012-2017
  • Molecular Diagnostics Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Molecular Diagnostics Segment: Competitive Structure, Global, 2013
  • Molecular Diagnostics Segment: Selection of FDA-cleared or -approved Tests, Global, 2013
  • Molecular Diagnostics Segment: Automated Molecular Platforms that Integrate Pre-analytical and Analytical Steps, Global, 2013
  • Molecular Diagnostics Segment: NGS Products, Global, 2013
  • Molecular Diagnostics Segment: Automated Molecular Platforms, Global, 2013
  • Hematology Segment: Market Engineering Measurements, Global, 2013
  • Hematology Segment: Revenue Forecast, Global, 2012-2017
  • Hematology Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Hematology Segment: Competitive Structure, Global, 2013
  • Hematology Segment: Installed Base, Global, 2013
  • Hematology Segment: Installed Base Split, Global, 2013
  • Hematology Segment: Hematology Products, Global, 2013
  • Clinical Microbiology Segment: Market Engineering Measurements, Global, 2013
  • Clinical Microbiology Segment: Revenue Forecast, Global, 2012-2017
  • Clinical Microbiology Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Clinical Microbiology Segment: Competitive Structure, Global, 2013
  • Clinical Microbiology Segment: Technology Trends, Global, 2011-2015
  • Hemostasis Segment: Market Engineering Measurements, Global, 2013
  • Hemostasis Segment: Revenue Forecast, Global, 2012-2017
  • Hemostasis Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Hemostasis Segment: Competitive Structure, Global, 2013
  • Hemostasis Segment: Hemostasis Tests, Global, 2013
  • Hemostasis Segment: Hemostasis Analyzers, Global, 2013
  • Tissue Diagnostics Segment: Market Engineering Measurements, Global, 2013
  • Tissue Diagnostics Segment: Revenue Forecast, Global, 2012-2017
  • Tissue Diagnostics Segment: Revenue Forecast by Subsegment, Global, 2012-2017
  • Tissue Diagnostics Segment: Percent of Sales, United States, 2013
  • Tissue Diagnostics Segment: Percent of Sales, Western Europe 2013
  • Tissue Diagnostics Segment: Competitive Structure, Global, 2013
  • Total IVD Market: Percent Revenue by Region, Global, 2012-2017
  • Total IVD Market: Growth by Region, Global, 2012-2017
  • IVD Market: Revenue Forecast, United States, 2012-2017
  • IVD Market: Revenue Forecast, Western Europe, 2012-2017
  • IVD Market: Revenue Forecast, Asia-Pacific and China, 2012-2017
  • IVD Market: Revenue Forecast, Brazil, 2012-2017
  • IVD Market: Revenue Forecast, Eastern Europe, 2012-2017
  • IVD Market: Revenue Forecast, Rest of World, 2012-2017
Back to Top